Evaluation of the interaction between acemetacin and opioids on the hargreaves model of thermal hyperalgesia

Pharmacology Biochemistry and Behavior

Volumn 88, Issue 1, 2007, Pages 47-54

  Ortiz, Mario I ^a   Ponce Monter, Héctor ^a   Fernández Martínez, Eduardo ^a   Pérez Hernández, Nury ^a   Macías, Arturo ^a   Rangel Flores, Eduardo ^a   Castañeda Hernández, Gilberto ^b  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Acemetacin; Codeine; Mouse; Nalbuphine; Synergism; Thermal hyperalgesia

Indexed keywords

ACEMETACIN; BUFIGEN; CARRAGEENAN; CODEINE; NALBUPHINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; HYPERALGESIA; LOW DRUG DOSE; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CODEINE; DATA INTERPRETATION, STATISTICAL; DRUG INTERACTIONS; HEAT; HYPERALGESIA; INDOMETHACIN; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; NALBUPHINE;

MUS;

EID: 34548537014     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.07.003     Document Type: Article

References (72)

1. Badia-Flores J., and Muñoz Barradas F. Treatment of chronic polyarthritis with acemetacin and indomethacin. Arzneimittelforschung 30 (1980) 1433-1437
2. Bhat A.S., Tandan S.K., Kumar D., Krishna V., and Prakash V.R. Interaction between inhibitors of inducible nitric oxide synthase and cyclooxygenase in adjuvant-induced arthritis in female albino rats: an isobolographic study. Eur J Pharmacol 556 (2007) 190-199
3. Bileviciute-Ljungar I., Spetea M., Guo Y., Schutz J., Windisch P., and Schmidhammer H. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl) amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation. J Pharmacol Exp Ther 317 (2006) 220-227
4. Bombardier C. An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol 89 (2002) 3D-9D
5. Bori-Segura G., Torres y Gutierrez-Rubio A., Herrera-Gomez L.E., and Olguin-Uribe J. Efficacy and tolerability of acemetacin, a non-steroidal anti-inflammatory drug, in Mexican patients: result of the ETAPAM Study. Proc West Pharmacol Soc 45 (2002) 104-107
6. Bourlert A. Diclofenac intramuscular single dose to decrease pain in post operative Caesarean section: a double blind randomized controlled trial. J Med Assoc Thai 88 (2005) 15-19
7. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352 (2005) 1092-1102
8. Cadet P. Mu opiate receptor subtypes. Med Sci Monit 10 (2004) MS28-MS32
9. Chen Z.R., Irvine R.J., Somogyi A.A., and Bochner F. Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 48 (1991) 2165-2171
10. Cherny N.I. Opioid analgesics: comparative features and prescribing guidelines. Drugs 51 (1996) 713-737
11. Chmielnicki Z. Nalbuphine-properties and clinical use. Wiad Lek 46 (1993) 139-142
12. Cleary J., Mikus G., Somogyi A., and Bochner F. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model. J Pharmacol Exp Ther 271 (1994) 1528-1534
13. Cohen R.I., Edwards W.T., Kezer E.A., Ferrari D.A., Liland A.E., and Smith E.R. Serial intravenous doses of dezocine, morphine, and nalbuphine in the management of postoperative pain for outpatients. Anesth Analg 77 (1993) 533-539
14. Cooper S.A., Engel J., Ladov M., Precheur H., Rosenheck A., and Rauch D. Analgesic efficacy of an ibuprofen-codeine combination. Pharmacotherapy 2 (1982) 162-167
15. Culebras X., Gaggero G., Zatloukal J., Kern C., and Marti R.A. Advantages of intrathecal nalbuphine, compared with intrathecal morphine, after cesarean delivery: an evaluation of postoperative analgesia and adverse effects. Anesth Analg 91 (2000) 601-605
16. Curatolo M., and Sveticic G. Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best Pract Res Clin Anaesthesiol 16 (2002) 507-519
17. Czuczwar M., Kis J., Luszczki J., Turski W.A., and Przesmycki K. Evaluation of interaction between gabapentin and baclofen in the formalin test in mice. Pol J Pharmacol 55 (2003) 803-806
18. de Craen A.J., Di Giulio G., Lampe-Schoenmaeckers J.E., Kessels A.G., and Kleijnen J. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. BMJ 313 (1996) 321-325
19. de Lima J., Lloyd-Thomas A.R., Howard R.F., Sumner E., and Quinn T.M. Infant and neonatal pain: anaesthetists' perceptions and prescribing patterns. BMJ 313 (1996) 787
20. Dionne R.A., Lepinski A.M., Gordon S.M., Jaber L., Brahim J.S., and Hargreaves K.M. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther 70 (2001) 66-73
21. Fiorucci S., Antonelli E., and Morelli A. Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis 33 (2001) S35-S43
22. Fletcher D., Benoist J.M., Gautron M., and Guilbaud G. Isobolographic analysis of interactions between intravenous morphine, propacetamol, and diclofenac in carrageenin-injected rats. Anesthesiology 87 (1997) 317-326
23. Forbes J.A., Keller C.K., Smith J.W., Zeleznock J.R., Sevelius H., and Beaver W.T. Analgesic effect of naproxen sodium, codeine, a naproxen-codeine combination and aspirin on the postoperative pain of oral surgery. Pharmacotherapy 6 (1986) 211-218
24. Goldstein F.J. Adjuncts to opioid therapy. J Am Osteopath Assoc 102 (2002) S15-S21
25. Granados-Soto V., and Argüelles C.F. Synergic antinociceptive interaction between tramadol and gabapentin after local, spinal and systemic administration. Pharmacology 74 (2005) 200-208
26. Guevara-López U. Acemetacina: Características farmacológicas y clínicas. Rev Mex Anesth 27 (2004) 33-56
27. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
28. Hau V.S., Huber J.D., Campos C.R., Davis R.T., and Davis T.P. Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Res 1018 (2004) 257-264
29. Hawkey C.J. COX-2 inhibitors. Lancet 353 (1999) 307-314
30. Hoskin P.J., and Hanks G.W. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs 41 (1991) 326-344
31. Jacobi H., and Dell H.D. On the pharmacodynamics of acemetacin (author's transl). Arzneimittelforschung 30 (1980) 1348-1362
32. Jain A.K., Ryan J.R., McMahon F.G., and Smith G. Comparison of oral nalbuphine, acetaminophen, and their combination in postoperative pain. Clin Pharmacol Ther 39 (1986) 295-299
33. Jiménez-Andrade J.M., Ortiz M.I., Pérez-Urizar J., Aguirre-Bañuelos P., Granados-Soto V., and Castañeda-Hernández G. Synergistic effects between codeine and diclofenac after local, spinal and systemic administration. Pharmacol Biochem Behav 76 (2003) 463-471
34. Jones C.K., Peters S.C., and Shannon H.E. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. J Pharmacol Exp Ther 312 (2005) 726-732
35. Lahdesmaki J., Scheinin M., Pertovaara A., and Mansikka H. The alpha2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception. Eur J Pharmacol 468 (2003) 183-189
36. Leeb B.F., Bucsi L., Keszthelyi B., Bohmova J., Valesova M., Hawel R., et al. Treatment of osteoarthritis of the knee joint. Efficacy and tolerance to acemetacin slow release in comparison to celecoxib. Orthopade 33 (2004) 1032-1041
37. Litkowski L.J., Christensen S.E., Adamson D.N., Van Dyke T., Han S.H., and Newman K.B. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, par-allel-group study in a dental pain model. Clin Ther 27 (2005) 418-429
38. Menendez L., Lastra A., Hidalgo A., and Baamonde A. Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J Neurosci Methods 113 (2002) 91-97
39. Mignat C., Wille U., and Ziegler A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci 56 (1995) 793-799
40. Monrigal C., Jacob J.P., and Granry J.C. Comparison of the analgesic efficacy of nalbuphine and its combination with propacetamol during the immediate postoperative period in gynecologic-obstetric surgery. Ann Fr Anesth Reanim 13 (1994) 153-157
41. Mukherjee D., Nissen S.E., and Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286 (2001) 954-959
42. Muller P., Dammann H.G., and Simon B. Gastroduodenal tolerability of indomethacin and acetaminophen. A comparative endoscopic study in healthy subjects. Arzneimittelforschung 36 (1986) 269-270
43. + channels by nalbuphine on the formalin test. Eur J Pain 10 supp-1 (2006) S88
44. Ortiz M.I., Torres-López J.E., Castañeda-Hernández G., Rosas R., Vidal-Cantú G.C., and Granados-Soto V. Pharmacological evidence for the activation of K(+) channels by diclofenac. Eur J Pharmacol 438 (2002) 85-91
45. Ortiz M.I., Castañeda-Hernández G., and Granados-Soto V. Possible involvement of potassium channels in peripheral antinociception induced by metamizol: lack of participation of ATP-sensitive K+ channels. Pharmacol Biochem Behav 74 (2003) 465-470
46. Ortiz M.I., Castañeda-Hernández G., and Granados-Soto V. Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test. Pharmacol Biochem Behav 81 (2005) 725-731
47. Ortiz M.I., Castro-Olguín J., Peña-Samaniego N., and Castañeda-Hernández G. Probable activation of the opioid receptor-nitric oxide-cyclic GMP-K+ channels pathway by codeine. Pharmacol Biochem Behav 82 (2005) 695-703
48. Ossipov M.H., Lozito R., Messineo E., Green J., Harris S., and Lloyd P. Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis. Life Sci 47 (1990) PL71-PL76
49. Parsons C.G., West D.C., and Headley P.M. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration. Br J Pharmacol 98 (1989) 533-543
50. Picazo A., Castañeda-Hernández G., and Ortiz M.I. Examination of the interaction between peripheral diclofenac and gabapentin on the 5% formalin test in rats. Life Sci 79 (2006) 2283-2287
51. Pick C.G., Paul D., and Pasternak G.W. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice. J Pharmacol Exp Ther 262 (1992) 1044-1050
52. Picker M.J., and Dykstra L.A. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists. J Pharmacol Exp Ther 249 (1989) 557-566
53. Raffa R.B., Stone Jr. D.J., and Tallarida R.J. Discovery of "self-synergistic" spinal/supraspinal antinociception produced by acetaminophen (paracetamol). J Pharmacol Exp Ther 295 (2000) 291-294
54. Rahimi S.Y., Vender J.R., Macomson S.D., French A., Smith J.R., and Alleyne Jr. C.H. Postoperative pain management after craniotomy: evaluation and cost analysis. Neurosurgery 59 (2006) 852-857
55. Reuben S.S., and Connelly N.R. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 91 (2000) 1221-1225
56. Schmidt W.K., Tam S.W., Shotzberger G.S., Smith Jr. D.H., Clark R., and Vernier V.G. Nalbuphine. Drug Alcohol Depend 14 (1985) 339-362
57. Semple D., Russell S., Doyle E., and Aldridge L.M. Comparison of morphine sulphate and codeine phosphate in children undergoing adenotonsillectomy. Paediatr Anaesth 9 (1999) 135-138
58. Simon E.J. Recent studies on opioid receptors: heterogeneity and purification. Ann N Y Acad Sci 463 (1986) 31-45
59. Stoneham M.D., and Walters F.J. Post-operative analgesia for craniotomy patients: current attitudes among neuroanaesthetists. Eur J Anaesthesiol 12 (1995) 571-575
60. Strobel E. Drug therapy in severe tumor pain. Comparative study of a new combination preparation versus diclofenac-Na. Fortschr Med 110 (1992) 411-414
61. Talhari C., Lauceviciute I., Enderlein E., Ruzicka T., and Homey B. COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions. J Allergy Clin Immunol 115 (2005) 1089-1090
62. Tallarida R.J. Statistical analysis of drugs combinations for synergism. Pain 49 (1992) 93-97
63. Tallarida R.J. Drug synergism and dose-effect data analysis. 1st. Ed. (2000), Chapman & Hall/CRC, New York 1-72
64. Tallarida R.J. The interaction index: a measure of drug synergism. Pain 98 (2002) 163-168
65. Tallarida R.J., Stone D.J., McCarty J.D., and Raffa R.B. Response surface analysis of synergism between morphine and clonidine. J Pharmacol Exp Ther 289 (1999) 8-13
66. Tavares I.A., and Bennett A. Acemetacin and indomethacin: differential inhibition of constitutive and inducible cyclo-oxygenases in human gastric mucosa and leucocytes. Int J Tissue React 15 (1993) 49-53
67. Vaz Z.R., Filho V.C., Yunes R.A., and Calixto J.B. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice. J Pharmacol Exp Ther 278 (1996) 304-312
68. Voilley N., de Weille J., Mamet J., and Lazdunski M. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci 21 (2001) 8026-8033
69. Wolfe M.M., Lichtenstein D.R., and Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340 (1999) 1888-1899
70. Yoon M.H., and Yaksh T.L. The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in the rat. Anesth Analg 89 (1999) 434-439
71. Yue Q.Y., Hasselstrom J., Svensson J.O., and Sawe J. Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol 31 (1991) 635-642
72. Zimmermann M. Ethical guidelines for investigations on experimental pain in conscious animals. Pain 16 (1983) 109-110